See what questions
a doctor would ask.
Cymbalta has been recently approved by the FDA for use in pain management for sufferers of diabetic peripheral neuropathy. 62% of diabetic patients will develop this condition and is associated with sensations of burning, tingling and numbness. Clinical trials of the product have shown significant pain relief in many and the main side effects were nausea, dry mouth, constipation, diarrhea, dizziness and hot flashes.
Source: summary of medical news story as reported by Onlypunjab
About: Drug approved for treatment of diabetic peripheral neuropathy
Date: 21 October 2004
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City